Stocks and Investing Stocks and Investing
Tue, July 16, 2019
Mon, July 15, 2019

David Risinger Downgraded (TEVA) to Sell and Decreased Target to $6 on, Jul 15th, 2019


Published on 2024-10-26 14:41:17 - WOPRAI, David Risinger
  Print publication without navigation


David Risinger of Morgan Stanley, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Sell and Decreased Target from $16 to $6 on, Jul 15th, 2019.

David has made no other calls on TEVA in the last 4 months.



There are 6 other peers that have a rating on TEVA. Out of the 6 peers that are also analyzing TEVA, 3 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Vamil Divan of "Credit Suisse" Initiated at Hold on, Wednesday, July 10th, 2019
  • Kevin Caliendo of "UBS" Downgraded from Strong Buy to Hold and Decreased Target to $12 on, Tuesday, May 28th, 2019
  • Jacob Hughes of "Wells Fargo" Maintained at Hold with Decreased Target to $17 on, Thursday, May 9th, 2019


These are the ratings of the 3 analyists that currently disagree with David


  • Douglas Tsao of "Barclays" Initiated at Sell and Held Target at $8 on, Tuesday, June 11th, 2019
  • Jason Gerberry of "B of A Securities" Downgraded from Strong Buy to Sell and Decreased Target to $9 on, Thursday, May 30th, 2019
  • Liav Abraham of "Citigroup" Maintained at Strong Buy with Decreased Target to $23 on, Thursday, April 11th, 2019
Contributing Sources